Pathophysiological advances in membranous nephropathy: time for a shift in patient's care (Q38385835)

2 September 2017

1 reference

title

Pathophysiological advances in membranous nephropathy: time for a shift in patient's care (English)

1 reference

2 September 2017

1 reference

1 reference

Pierre Ronco

1

1 reference

PubMed ID

26090644

2 September 2017

Hanna Debiec

series ordinal

2

1 reference

PubMed ID

26090644

2 September 2017

language of work or name

English

0 references

publication date

1 May 2015

1 reference

2 September 2017

1 reference

2 September 2017

385

1 reference

2 September 2017

9981

1 reference

2 September 2017

1983-1992

1 reference

The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Treatment of idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Rituximab in Primary Membranous Nephropathy: First-Line Therapy, Why Not?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Antenatal Membranous Glomerulonephritis Due to Anti–Neutral Endopeptidase Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Membranous nephropathy in children: clinical presentation and therapeutic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Idiopathic membranous nephropathy: diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

The natural history of the non-nephrotic membranous nephropathy patient

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Management of membranous nephropathy: when and what for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Diagnosis and natural course of membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

IgG subclasses and complement pathway in segmental and global membranous nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Experimental glomerulonephritis in the isolated perfused rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Pathomechanisms and molecular basis of membranous glomerulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Electrical charge. Its role in the pathogenesis and prevention of experimental membranous nephropathy in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Complement regulation in renal disease models

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

The intersecting roles of endoplasmic reticulum stress, ubiquitin- proteasome system, and autophagy in the pathogenesis of proteinuric kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Genetic homogeneity but IgG subclass-dependent clinical variability of alloimmune membranous nephropathy with anti-neutral endopeptidase antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Early-childhood membranous nephropathy due to cationic bovine serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Allo-immune membranous nephropathy and recombinant aryl sulfatase replacement therapy: a need for tolerance induction therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Hepatitis B virus-associated nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Idiopathic membranous nephropathy in 2 twin brothers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Membranous nephropathy in two human leukocyte antigen-identical brothers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

A DQA1 allele is strongly associated with idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Correlation between B lymphocyte abnormality and disease activity in patients with idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

IgG4 breaking the rules

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Glomerular deposition of mannose-binding lectin in human glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

The role of complement in membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

sPLA2 IB induces human podocyte apoptosis via the M-type phospholipase A2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

The M-type receptor PLA2R regulates senescence through the p53 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Accelerated expression of senescence associated cell cycle inhibitor p16INK4A in kidneys with glomerular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Nephrotic syndrome: A new specific test for idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Anti-phospholipase A2 receptor antibody in membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

A case of phospholipase A₂ receptor-positive membranous nephropathy preceding sarcoid-associated granulomatous tubulointerstitial nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Pathogenesis of membranous nephropathy: recent advances and future challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

PLA2R autoantibodies and recurrent membranous nephropathy after transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Very Early Recurrence of Anti-Phospholipase A2 Receptor-Positive Membranous Nephropathy After Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

Phospholipase A2 receptor (PLA2R) staining is useful in the determination of de novo versus recurrent membranous glomerulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960731-0

7 January 2021

10.1016/S0140-6736(15)60731-0

Identifiers

DOI

1 reference

2 September 2017

1 reference

PubMed ID

26090644